Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein

Histochemistry and Cell Biology

Volumn 135, Issue 4, 2011, Pages 409-417

  Egervári, Gábor ^a   Márk, Ágnes ^a   Hajdu, Melinda ^a   Barna, Gábor ^a   Sápi, Zoltán ^a   Krenács, Tibor ^a   Kopper, László ^a   Sebestyén, Anna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cell cycle progression; Lymphomas; Mitosis; mTOR activity; S6 activity

Indexed keywords

NOCODAZOLE; NUCLEAR PROTEIN; PROTEIN RIBOSOMAL S6; RAPAMYCIN; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; HUMAN; HUMAN TISSUE; LYMPHOMA CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR BIOPSY;

BLOTTING, WESTERN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MITOSIS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6; TUMOR CELLS, CULTURED;

EID: 79956196878     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-011-0803-5     Document Type: Article

References (34)

1. Abraham RT, Gibbons JJ (2007) The mammalian target of rapamycin signaling pathway: twist and turns in the road to cancer therapy. Clin Cancer Res 3:3109-3114 (Pubitemid 46944891)
2. Boulay A, Lane HA (2007) The mammalian target of rapamycin kinase and tumor growth inhibition. Recent Results Cancer Res 172:99-124
3. Chaturvedi D, Poppleton HM, Stringfield T, Barbier A, Patel TB (2006) Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase. Mol Cell Biol 26:4586-4600 (Pubitemid 43877577)
4. Cho YY, He Z, Zhang Y, Choi HS, Zhu F, Choi BY et al (2005) The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction. Cancer Res 65:3596-3604
5. Costa LJ (2007) Aspects of mTOR biology and the use of mTOR inhibitors in non-Hodgkin's lymphoma. Cancer Treat Rev 33:78-84
6. Craxton A, Otipoby KL, Jiang A, Clark EA (1999) Signal transduction pathways that regulate the fate of B lymphocytes. Adv Immunol 73:79-152 (Pubitemid 29300429)
7. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P et al (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808
8. Fenton TR, Gout IT (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. Int J Biochem Cell Biol 43:47-59
9. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Blenis J (2004) mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24:200-216 (Pubitemid 38010048)
10. Hayashi M, Fearns C, Eliceiri B, Yang Y, Lee JD (2005) Big Mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis. Cancer Res 65:7699-7706 (Pubitemid 41297244)
11. Kim D, Akcakanat A, Singh G, Shama C, Meric-Berstam F (2009) Regulation and localization of ribosomal protein S6 kinase 1 isoforms. Growth Factors 27:12-21
12. LoPicollo J, Blumenthal GM, Bernstein WB, Dennis PA (2008) Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical consideration. Drug Resist Updat 11:32-50
13. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S et al (2008) The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. Clin Invest 118:3917-3929
14. Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N (2006) mTOR, translation initiation and cancer. Oncogene 25:6416-6422 (Pubitemid 44582285)
15. Meyuhas O (2008) Physiological roles of ribosomal protein S6: one of its kind. Int Rev Cell Mol Biol 268:1-37
16. Nakagawa M, Ohmido N, Ishikawa K, Uchiyama S, Fukui K, Azuma T (2008) Anti-peptide antibodies for examining the conformation, molecular assembly and localization of an intracellular protein S6, in vivo. J Biochem 143:325-332 (Pubitemid 351363949)
17. Pearce LR, Alton GR, Richter DT, Kath JC, Lingardo L, Chapman J, Hwang C, Alessi DR (2010) Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem J 431(2):245-255
18. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J et al (2004) S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin sensitive 5′ terminal oligopyrimidine mRNAS translation and reveal a mitogen-activated protein kinase dependent S6 kinase pathways. Mol Cell Biol 24:3112-3124 (Pubitemid 38452057)
19. Peterson RT, Schreiber SL (1998) Translation control: connecting mitogens and the ribosome. Curr Biol 8:248-250
20. Rossi R, Pester JM, McDowell M, Soza S, Montecucco A, Lee-Fruman KK (2007) Identification of S6K2 as a centrosome-located kinase. FEBS Lett 581:4058-4064 (Pubitemid 47212118)
21. Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jaquot S et al (1999) Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285:886-891 (Pubitemid 29381988)
22. Schmidt T, Whal P, Wüthrich RP, Vogetseder A, Picard N, Kaissling B et al (2007) Immunolocalization of phospho-S6 kinase: a new way to detect mitosis in tissue sections and in cell culture. Histochem Cell Biol 127:123-129 (Pubitemid 46151050)
23. Schouten GJ, Vertegaal AC, Whiteside ST, Israel A, Toebes M, Dorsman JC et al (1997) IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J 16:3133-3144 (Pubitemid 27234953)
24. Shah OJ, Ghosh S, Hunter T (2003) Mitotic regulation of ribosomal S6 kinase 1 involves Ser/thr, Pro phosphorylation of consensus and non-consensus sites by Cdc2. J Biol Chem 278:16433-16442 (Pubitemid 36799771)
25. Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW (1999) Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274:2893-2898 (Pubitemid 29075375)
26. Stoeltzing O, Meric-Bernstam F, Ellis LM (2006) Intracellular signaling in tumor and endothelial cells: the expected and, yet again, the unexpected. Cancer Cell 10:89-91 (Pubitemid 44175909)
27. Stolovich M, Tang H, Hornstein E, Levy G, Bae SS, Birnbaum MJ et al (2002) Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the PI3-kinase mediated pathway, but requires neither S6K nor S6 phosphorylation. Mol Cell Biol 22:8101-8113 (Pubitemid 35304044)
28. Sudakin V, Yen TJ (2007) Targeting mitosis for anti-cancer therapy. BioDrugs 21:225-233 (Pubitemid 47104978)
29. Tang H, Hornstein E, Stolovich M, Levy G, Livingstone M, Templeton D et al (2001) Amino acid-induced translation of TOP mRNAs is fully dependent on PI3-kinase mediated signaling, partly inhibited by rapamycin, and it is independent of S6K1 and S6 phosphorylation. Mol Cell Biol 21:8671-8683 (Pubitemid 33108623)
30. Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A (2010) Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma. J Hematol Oncol 3:30-31
31. Willard FS, Crouch MF (2001) MEK, Erk, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for MAk kinase pathway in regulating mitotic exit. Cell Signal 13:653-664
32. Yaba A, Bianchi V, Borini A, Johnson (2008) A putative mitotic checkpoint dependent on mTOR function controls cell proliferation and survival in ovarian granulosa cells. Reprod Sci 15:128-138 (Pubitemid 351903539)
33. Zhao MY, Auerbach A, D'Costa AM et al (2009) Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy. Clin Cancer Res 15:1708-1720
34. Zheng B, Shorthouse R, Masek MA, Berry G, Billingham ME, Morris RE (1991) Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo. Transplant Proc 23:851-855